Could skipping a key IVF drug make treatment easier and cheaper?
NCT ID NCT06879002
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two approaches to ovarian stimulation for IVF. The standard method uses a drug (GnRH antagonist) to prevent early ovulation. The new method starts stimulation after ovulation, relying on the body's natural progesterone to prevent early ovulation, potentially reducing the number of injections. The study will enroll 252 women aged 18-38 with normal cycles to see if the simpler approach works just as well.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IVF OUTCOME are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ART Fertility Clinics LLC
Abu Dhabi, United Arab Emirates
-
ART Fertility Clinics LLC - Dubai
Dubai, United Arab Emirates
More trials for these conditions
Other studies related to the condition(s) this trial covers.